We are thrilled to announce that Takis has been selected among 13 European companies for the IPCEI “Med4Cure” project, the first Important Project of Common European Interest in the Health value chain.
The Med4Cure project supports #research, innovation and the industrial deployment of pioneering #healthcare products and processes. Our project, Zetesis X-eVax, aims to create an Italian center of excellence for research and development, focusing on innovative #vaccines and hashtag#gene therapies. This includes developing new generation vaccines for COVID-19 and Malaria, as well as #cancer treatments. Being […]